| |
| |
|
| Insider
Information: |
Machiels Alec |
| Relationship: |
Director |
| City: |
Greenwood Village |
| State: |
CO |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
377,113 |
|
|
Indirect Shares
|
411,950 |
|
|
| Direct
Value |
$18,486,143 |
|
|
|
Indirect Value
|
$20,539,827 |
|
|
| Total
Shares |
789,063 |
|
|
| Total
Value |
$39,025,970 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Apellis Pharmaceuticals Inc |
APLS |
Director |
2024-01-01 |
370,761 |
2024-01-01 |
411,950 |
Premium* |
|
|
Creative Realities Inc |
CREX |
Director |
2019-10-01 |
6,352 |
2019-07-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2024-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,341 |
370,761 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2023-11-17 |
4 |
AS |
$47.74 |
$59,675 |
D/D |
(1,250) |
367,420 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2023-11-17 |
4 |
OE |
$2.67 |
$3,338 |
D/D |
1,250 |
368,670 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2023-10-17 |
4 |
AS |
$48.50 |
$60,625 |
D/D |
(1,250) |
367,420 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2023-10-17 |
4 |
OE |
$2.67 |
$3,338 |
D/D |
1,250 |
368,670 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2023-09-18 |
4 |
OE |
$2.67 |
$3,338 |
D/D |
1,250 |
368,670 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2023-09-18 |
4 |
AS |
$45.00 |
$56,250 |
D/D |
(1,250) |
367,420 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2023-09-15 |
4 |
AS |
$45.34 |
$56,675 |
D/D |
(1,250) |
367,420 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2023-09-15 |
4 |
OE |
$2.67 |
$3,338 |
D/D |
1,250 |
368,670 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2023-07-21 |
4 |
OE |
$2.67 |
$132,910 |
D/D |
49,779 |
367,420 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2023-07-20 |
4 |
OE |
$2.67 |
$133,500 |
D/D |
50,000 |
317,641 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2023-07-17 |
4 |
OE |
$2.67 |
$3,338 |
D/D |
1,250 |
268,891 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2023-07-17 |
4 |
AS |
$64.79 |
$80,988 |
D/D |
(1,250) |
267,641 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2023-06-20 |
4 |
AS |
$88.41 |
$110,513 |
D/D |
(1,250) |
267,641 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2023-06-20 |
4 |
OE |
$2.67 |
$3,338 |
D/D |
1,250 |
268,891 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2023-05-17 |
4 |
AS |
$88.66 |
$110,825 |
D/D |
(1,250) |
267,641 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2023-05-17 |
4 |
OE |
$2.67 |
$3,338 |
D/D |
1,250 |
268,891 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2023-04-17 |
4 |
OE |
$2.67 |
$3,338 |
D/D |
1,250 |
268,891 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2023-04-17 |
4 |
AS |
$81.05 |
$101,313 |
D/D |
(1,250) |
267,641 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2023-03-17 |
4 |
AS |
$64.03 |
$80,038 |
D/D |
(1,250) |
267,641 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2023-03-17 |
4 |
OE |
$2.67 |
$3,338 |
D/D |
1,250 |
268,891 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2023-02-17 |
4 |
AS |
$52.38 |
$65,475 |
D/D |
(1,250) |
267,641 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2023-02-17 |
4 |
OE |
$2.67 |
$3,338 |
D/D |
1,250 |
268,891 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2023-01-17 |
4 |
AS |
$52.42 |
$65,525 |
D/D |
(1,250) |
267,641 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2023-01-17 |
4 |
OE |
$2.67 |
$3,338 |
D/D |
1,250 |
268,891 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
